American Samoa vs Fiji: Treatment coverage for lymphatic filariasis
American Samoa
33.9%
in 2022
Fiji
41.7%
in 2023
American Samoa rank
45th
Fiji rank
43rd
Treatment coverage for lymphatic filariasis over time
- American Samoa
- Fiji
How they compare
Fiji currently reports 41.7% against 33.9% in American Samoa, a difference of 7.8%.
That makes Fiji's figure about 1.2 times American Samoa's.
The two have swapped places 7 times across 13 shared years of data; in 2002 it was Fiji ahead.
American Samoa ranks 45th and Fiji ranks 43rd of 66 countries.
Across the 3 decades both report, American Samoa averaged higher in 1 and Fiji in 2.
Head to head by decade
| Decade | American Samoa | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 37.9% | 49.8% | 11.9% | Fiji |
| 2010s | 49.9% | 58.3% | 8.4% | Fiji |
| 2020s | 11.3% | 6.7% | 4.6% | American Samoa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for lymphatic filariasis, American Samoa or Fiji?
- Fiji, at 41.7% against 33.9% in American Samoa as of 2023.
- What is the difference in treatment coverage for lymphatic filariasis between American Samoa and Fiji?
- 7.8%, with Fiji ahead.
- How many years of comparable data are there for American Samoa and Fiji?
- 13 years are reported by both, from 2002 to 2022.
- How do American Samoa and Fiji rank globally for treatment coverage for lymphatic filariasis?
- American Samoa ranks 45th and Fiji ranks 43rd of 66 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for lymphatic filariasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.